研究者詳細 - 佐治　重衡

論文 - 佐治　重衡

分割表示226 件中 41 - 60 件目／全件表示 >>

Ipatasertib plus Paclitaxel for patients with PIK3CA/AKT1/PTEN-Altered Locally Advanced Unresectable or Metastatic Triple-Negative Breast Cancer in the IPATunity130 Phase III Trial.

Dent RA, Kim SB, Oliveira M, Barrios C, O'Shaughnessy J, Isakoff SJ, Saji S, Freitas-Junior R, Philco M, Bondarenko I, Lian Q, Bradley D, Hinton H, Wongchenko MJ, Reilly SJ, Turner N.

Clin Cancer Res. 30 ( 19 ) 4329 - 4338 2024年10月

Impact of immediate breast reconstruction on perioperative therapy: insights from a Japanese Nationwide Registry.

Sasada S, Kumamaru H, Hayashi N, Kinukawa N, Toi M, Jinno H, Saji S.

Breast Cancer. 31 ( 5 ) 909 - 916 2024年9月

進化する乳癌治療

佐治重衡、戸井雅和

Animus 119 3 - 10 2024年7月

Treatment patterns and clinical outcomes in patients with metastatic triple-negative breast cancer: a large-scale data analysis using the Japanese claims database.

Kimura T, Takami T, Piao Y, Ntalla I, Saji S.

Breast Cancer Res Treat. 206 ( 1 ) 91 - 103 2024年7月

Real-world data of HER2-negative early breast cancer patients treated with anthracycline and/or taxane regimens in Japan.

Shimomura A, Sagara Y, Koto R, Fujiwara M, Kanemura Y, Kitagawa H, Saji S.

Breast Cancer. 31 ( 4 ) 581 - 592 2024年7月

The Japanese breast cancer society clinical practice guidelines for radiation treatment of breast cancer, 2022 edition.

Yoshimura M, Yamauchi C, Sanuki N, Hamamoto Y, Hirata K, Kawamori J, Kawamura M, Ogita M, Yamamoto Y, Iwata H, Saji S.

Breast Cancer. 31 ( 3 ) 347 - 357 2024年5月

Trastuzumab deruxtecan for human epidermal growth factor receptor 2-low advanced or metastatic breast cancer: recommendations from the Japanese Breast Cancer Society Clinical Practice Guidelines.

Hattori M, Honma N, Nagai S, Narui K, Shigechi T, Ozaki Y, Yoshida M, Sakatani T, Sasaki E, Tanabe Y, Tsurutani J, Takano T, Saji S, Masuda S, Horii R, Tsuda H, Yamaguchi R, Toyama T, Yamauchi C, Toi M, Yamamoto Y.

Breast Cancer. 31 ( 3 ) 335 - 339 2024年5月

The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment.

Yamamoto Y, Yamauchi C, Toyama T, Nagai S, Sakai T, Kutomi G, Yoshimura M, Kawai M, Ohtani S, Kubota K, Nakashima K, Honma N, Yoshida M, Tokunaga E, Taira N, Iwata H, Saji S.

Breast Cancer. 31 ( 3 ) 340 - 346 2024年5月

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with early breast cancer.

Park KH, Loibl S, Sohn J, Park YH, Jiang Z, Tadjoedin H, Nag S, Saji S, Md Yusof M, Villegas EMB, Lim EH, Lu YS, Ithimakin S, Tseng LM, Dejthevaporn T, Chen TW, Lee SC, Galvez C, Malwinder S, Kogawa T, Bajpai J, Brahma B, Wang S, Curigliano G, Yoshino T, Kim SB, Pentheroudakis G, Im SA, Andre F, Ahn JB, Harbeck N

ESMO open 9 ( 5 ) 102974 2024年5月

Treatment patterns, healthcare resource utilization and outcomes for early stage triple-negative breast cancer in Japan.

Sanno H, Taniguchi K, Yoshimoto Y, Saji S

Future Oncol. 20 ( 13 ) 833 - 849 2024年4月

Identifying prognostic biomarkers for palbociclib add-on therapy in fulvestrant-resistant breast cancer using cell-free DNA sequencing.

Takeshita T, Iwamoto T, Niikura N, Watanabe K, Kikawa Y, Kobayashi K, Iwakuma N, Okamura T, Tada H, Ozaki S, Okuno T, Toh U, Yamamoto Y, Tsuneizumi M, Ishiguro H, Masuda N, Saji S

ESMO open 9 ( 4 ) 102385 2024年4月

Protecting the Brain: Novel Strategies for Preventing Breast Cancer Brain Metastases through Selective Estrogen Receptor β Agonists and In Vitro Blood-Brain Barrier Models.

Kirchner J, Völker E, Shityakov S, Saji S, Förster CY.

Int J Mol Sci 25 ( 6 ) 3379 2024年3月

進行・再発乳癌に対する治療成績の向上について

佐治重衡

癌と化学療法. 51 ( 3 ) 250 - 253 2024年3月

2020 Annual Report of National Clinical Database-Breast Cancer Registry: 10-year mortality of elderly breast cancer patients in Japan.

Sagara Y, Kumamaru H, Niikura N, Miyashita M, Konishi T, Iwamoto T, Sanuki N, Tanakura K, Nagahashi M, Hayashi N, Yoshida M, Kinukawa N, Watanabe C, Toi M, Saji S.

Breast Cancer. 31 ( 2 ) 179 - 184 2024年3月

Survival trends and patient characteristics between 2004 and 2016 for breast cancer in Japan based on the National Clinical Database-Breast Cancer Registry.

Iwamoto T, Kumamaru H, Niikura N, Sagara Y, Miyashita M, Konishi T, Sanuki N, Tanakura K, Nagahashi M, Hayashi N, Yoshida M, Watanabe C, Kinukawa N, Toi M, Saji S.

Breast Cancer. 31 ( 2 ) 185 - 194 2024年3月

The Japanese Breast Cancer Society clinical practice guidelines for epidemiology and prevention of breast cancer, 2022 edition.

Kawai M, Ohtani S, Iwasaki M, Yamamoto S, Takamatsu K, Okamura H, Arai M, Nomura T, Ozaki S, Shibata KI, Akabane A, Motoi F, Yamauchi C, Yamamoto Y, Iwata H, Saji S.

Breast Cancer. 31 ( 2 ) 166 - 178 2024年3月

2020年度のNational Clinical Database乳癌登録の年次報告　日本の高齢乳癌患者の10年死亡率(2020 Annual Report of National Clinical Database-Breast Cancer Registry: 10-year mortality of elderly breast cancer patients in Japan)

Sagara Yasuaki, Kumamaru Hiraku, Niikura Naoki, Miyashita Minoru, Konishi Takaaki, Iwamoto Takayuki, Sanuki Naoko, Tanakura Kenta, Nagahashi Masayuki, Hayashi Naoki, Yoshida Masayuki, Kinukawa Naoko, Watanabe Chie, Toi Masakazu, Saji Shigehira

Breast Cancer 31 ( 2 ) 179 - 184 2024年3月（ ISSN:1340-6868 ）

First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results.

Schmid P, Turner NC, Barrios CH, Isakoff SJ, Kim SB, Sablin MP, Saji S, Savas P, Vidal GA, Oliveira M, O'Shaughnessy J, Italiano A, Espinosa E, Boni V, White S, Rojas B, Freitas-Junior R, Chae Y, Bondarenko I, Lee J, Torres Mattos C, Martinez Rodriguez JL, Lam L, Jones S, Reilly SJ, Huang X, Shah K, Dent R.

Clin Cancer Res. 30 ( 4 ) 767 - 778 2024年2月

Risk factors for late recurrence and postrelapse survival in estrogen receptor (ER)-positive, human epidermal growth factor receptor (HER) 2-negative breast cancer after 5 years of endocrine therapy.

Ito M, Amari M, Sato A, Hikichi M, Sakamoto A, Yamazaki A, Saji S.

Breast 73 103604 2024年2月

The Japanese Breast Cancer Society Clinical Practice Guidelines for surgical treatment of breast cancer, 2022 edition.

Sakai T, Kutomi G, Shien T, Asaga S, Aruga T, Ishitobi M, Kuba S, Sawaki M, Terata K, Tomita K, Yamauchi C, Yamamoto Y, Iwata H, Saji S.

Breast Cancer. 31 ( 1 ) 1 - 7 2024年1月

　前のページ - 次のページ　

<佐治 重衡>

論文 - 佐治 重衡

<佐治　重衡>

論文 - 佐治　重衡